COMT and Parkinson disease: For PD, L-dopa, dopa decarboxylase inhibitors, catechol-O-methyltransferase (COMT) inhibitors, dopamine agonists, and monoamine oxidases (MAO) inhibitors are used to provide symptomatic relief [7].